Let’s Win! Pancreatic Cancer is an unprecedented platform that enables doctors, scientists, and patients to share fast-breaking information on potentially life-saving pancreatic cancer treatments and clinical trials. Our goal is to inform, enable, and educate patients and caregivers, providing easy-to-understand, actionable information. In this way we can help people find the best treatment options available.
Through Let’s Win!, patients and their families can share information about their diagnoses and the novel treatments they have undertaken beyond traditional protocols, and they can learn from experts how to better manage and improve their quality of life.
Dr. Andrew Coveler discusses the use of electric fields to disrupt cell division during pancreatic cancer treatment.
The Pancreatic Cancer Collective, a collaboration between the Lustgarten Foundation and Stand Up To Cancer, announced four recipients of further funding to develop new treatments for pancreatic cancer.
Learn what you should do to prevent the spread of COVID-19, especially if you have a weakened immune system from pancreatic cancer treatment.
Pancreatic cancer experts discuss treatment during the COVID-19 pandemic, along with other important issues for patients.
When you discover you have pancreatic cancer, your first inclination may be to hit the web. Here's some strategies to navigate the information overload.
The pancreas has many functions, and one of its most important roles is the regulation of blood sugar.
After Scott Nelson was diagnosed with pancreatic cancer, his older brother Steve joined a pancreatic cancer screening study.
Our short animation explains how to find a clinical trial that may be right for you and shows how to apply to participate.
Pancreatic cancer doctors and researchers share what motivates them to do better for pancreatic cancer patients.
The Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation (Elvin Howard, Sr. PCAF) and Let’s Win have released a new public service announcement (PSA) to raise awareness of pancreatic cancer in people of color.